Market Place
Sourcing Support
MSN`s Generics Nebivolol HCl Receives Approval in US
01 Oct 2024 //
FDA
Mankind`s Generic Nebivolol Hydrochloride Receives Approval in the U.S.
14 Nov 2022 //
FDA
Prinston`s Generic Nebivolol HCL, Valsartan Receives Approval in the U.S.
19 Sep 2022 //
FDA
ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results
08 Aug 2022 //
BUSINESS WIRE
PRINSTON `s Generic Nebivolol Hydrochloride Receives Approval in US
07 Apr 2022 //
FDA
Unichem`s Generic Nebivolol Hydrochloride Receives Approval in the U.S.
15 Mar 2022 //
FDA
AbbVie escapes antitrust claims over blood pressure med Bystolic
27 Jan 2022 //
FIERCEPHARMA
Reyoung`s Generic Nebivolol Hydrochloride Receives Approval in the U.S.
17 Dec 2021 //
FDA
Cadila Pharms` Generic Nebivolol Hydrochloride Receives Approval in the U.S.
17 Dec 2021 //
FDA
ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
17 Sep 2021 //
BUSINESSWIRE
Hetero Labs Unit`s Generic nebivolol hydrochloride Approval In US
06 Nov 2020 //
FDA
Valsartan products not currently recalled - Updated November 27, 2018
28 Nov 2018 //
FDA
Torrent Pharma`s Generic Olmesartan Medoxomil Receives Approval In US
08 Mar 2018 //
FDA
Bystolic® (Nebivolol Hydrochloride): Allergan Sales V. Aurobindo Pharma Usa
19 Jan 2018 //
PATENT LITIGATION
US says Allergan`s Units to Pay $38 Million to Settle Kickback Allegations
16 Dec 2016 //
REUTERS
Forest`s Byvalson (Nebivolol; Valsartan) approved in US for Hypertension
03 Jun 2016 //
FDA
Watson`s Generic Nebivolol Hydrochloride approved in US for Hypertension
01 Dec 2015 //
FDA
Alkem`s Generic Nebivolol Hcl Approved in US For Hypertension
27 Jun 2015 //
FDA
Actavis wins more hearts on Wall Street as `top 4` Morgan Stanley pick
19 May 2015 //
FIERCE PHARMA
Drug shortages become issue in Teva and Mylan hook-up
30 Apr 2015 //
FIERCE PHARMA MANUFACTURING
EMA Recommends Hundreds of Drugs to be Suspended Over "Flawed Studies"
24 Jan 2015 //
PHARMALOT
Actavis High Blood Pressure Drug Fails to Win U.S. Approval
25 Dec 2014 //
BLOOMBERG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.